A citation-based method for searching scientific literature

Aika Miya, Akinobu Nakamura, Takahisa Handa, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho, So Nagai, Hideaki Miyoshi, Tatsuya Atsumi. J Diabetes Investig 2021
Times Cited: 3







List of co-cited articles
12 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mean amplitude of glycemic excursions, a measure of diabetic instability.
F J Service, G D Molnar, J W Rosevear, E Ackerman, L C Gatewood, W F Taylor. Diabetes 1970
817
100



Time in range: a new parameter to evaluate blood glucose control in patients with diabetes.
Monica Andrade Lima Gabbay, Melanie Rodacki, Luis Eduardo Calliari, Andre Gustavo Daher Vianna, Marcio Krakauer, Mauro Scharf Pinto, Janice Sepúlveda Reis, Marcia Puñales, Leonardo Garcia Miranda, Ana Claudia Ramalho,[...]. Diabetol Metab Syndr 2020
11
66

Clinical factors associated with absolute and relative measures of glycemic variability determined by continuous glucose monitoring: an analysis of 480 subjects.
Sang-Man Jin, Tae-Hun Kim, Ji Cheol Bae, Kyu Yeon Hur, Myung-Shik Lee, Moon-Kyu Lee, Jae Hyeon Kim. Diabetes Res Clin Pract 2014
35
66

The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System.
Timothy Bailey, Bruce W Bode, Mark P Christiansen, Leslie J Klaff, Shridhara Alva. Diabetes Technol Ther 2015
289
66


Glycaemic variability and hypoglycaemia are associated with C-peptide levels in insulin-treated type 2 diabetes.
M B Christensen, P Gæde, E Hommel, A Gotfredsen, K Nørgaard. Diabetes Metab 2020
8
66

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
Tadej Battelino, Thomas Danne, Richard M Bergenstal, Stephanie A Amiel, Roy Beck, Torben Biester, Emanuele Bosi, Bruce A Buckingham, William T Cefalu, Kelly L Close,[...]. Diabetes Care 2019
542
66

International Consensus on Use of Continuous Glucose Monitoring.
Thomas Danne, Revital Nimri, Tadej Battelino, Richard M Bergenstal, Kelly L Close, J Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A Amiel,[...]. Diabetes Care 2017
560
66

Utility of indices using C-peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes.
Shogo Funakoshi, Shimpei Fujimoto, Akihiro Hamasaki, Hideya Fujiwara, Yoshihito Fujita, Kaori Ikeda, Shiho Takahara, Kazuaki Nagashima, Masaya Hosokawa, Yutaka Seino,[...]. J Diabetes Investig 2011
34
66

GlyCulator2: an update on a web application for calculation of glycemic variability indices.
Konrad Pagacz, Konrad Stawiski, Agnieszka Szadkowska, Wojciech Mlynarski, Wojciech Fendler. Acta Diabetol 2018
11
66

Concurrent Use of Teneligliptin and Canagliflozin Improves Glycemic Control with Beneficial Effects on Plasma Glucagon and Glucagon-Like Peptide-1: A Single-Arm Study.
Tomoho Noda, Emi Ebihara, Hiroaki Ueno, Keisuke Sadohara, Yuri Tanaka, Yuuma Nagatomo, Yousuke Murakami, Shinichi Yonamine, Wakaba Tsuchimochi, Hideyuki Sakoda,[...]. Diabetes Ther 2019
4
33

Favourable effect of the sodium-glucose co-transporter-2 inhibitor canagliflozin plus the dipeptidyl peptidase-4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open-label, prospective, randomized, parallel-group comparison trial (the CALMER study).
Kyu Yong Cho, Hiroshi Nomoto, Akinobu Nakamura, Shinichiro Kawata, Hajime Sugawara, Jun Takeuchi, So Nagai, Kazuhisa Tsuchida, Kazuno Omori, Hiroki Yokoyama,[...]. Diabetes Obes Metab 2020
5
33

Canagliflozin Increases Calorie Intake in Type 2 Diabetes Without Changing the Energy Ratio of the Three Macronutrients: CANA-K Study.
Ikuro Matsuba, Akira Kanamori, Masahiro Takihata, Masahiko Takai, Hajime Maeda, Akira Kubota, Kotaro Iemitsu, Shinichi Umezawa, Mitsuo Obana, Mizuki Kaneshiro,[...]. Diabetes Technol Ther 2020
4
33



Efficacy and safety of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes mellitus: Results of a 24-week, randomized, double-blind, placebo-controlled trial.
Takashi Kadowaki, Nobuya Inagaki, Kazuoki Kondo, Kenichi Nishimura, Genki Kaneko, Nobuko Maruyama, Nobuhiro Nakanishi, Hiroaki Iijima, Yumi Watanabe, Maki Gouda. Diabetes Obes Metab 2017
33
33

A randomized controlled trial comparing the effects of dapagliflozin and DPP-4 inhibitors on glucose variability and metabolic parameters in patients with type 2 diabetes mellitus on insulin.
Hiroshi Nomoto, Hideaki Miyoshi, Hajime Sugawara, Kota Ono, Shingo Yanagiya, Mayuko Oita, Akinobu Nakamura, Tatsuya Atsumi. Diabetol Metab Syndr 2017
16
33

Ameliorated pancreatic β cell dysfunction in type 2 diabetic patients treated with a sodium-glucose cotransporter 2 inhibitor ipragliflozin.
Mitsuyoshi Takahara, Toshihiko Shiraiwa, Taka-aki Matsuoka, Naoto Katakami, Iichiro Shimomura. Endocr J 2015
36
33

Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production.
Aurora Merovci, Carolina Solis-Herrera, Giuseppe Daniele, Roy Eldor, Teresa Vanessa Fiorentino, Devjit Tripathy, Juan Xiong, Zandra Perez, Luke Norton, Muhammad A Abdul-Ghani,[...]. J Clin Invest 2014
454
33



Correlates of quality of life in older adults with diabetes: the diabetes & aging study.
Neda Laiteerapong, Andrew J Karter, Jennifer Y Liu, Howard H Moffet, Rebecca Sudore, Dean Schillinger, Priya M John, Elbert S Huang. Diabetes Care 2011
108
33

Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Pouya Saeedi, Inga Petersohn, Paraskevi Salpea, Belma Malanda, Suvi Karuranga, Nigel Unwin, Stephen Colagiuri, Leonor Guariguata, Ayesha A Motala, Katherine Ogurtsova,[...]. Diabetes Res Clin Pract 2019
934
33

2019 Endocrine Society Measures Set for Older Adults With Type 2 Diabetes Who Are at Risk for Hypoglycemia.
James L Rosenzweig, Paul R Conlin, Jasmine D Gonzalvo, Stephanie B Kutler, Nisa M Maruthur, Penelope Solis, Sandeep Vijan, Amisha Wallia, Robin Fein Wright. J Clin Endocrinol Metab 2020
1
100

Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus.
Kristine Yaffe, Cherie M Falvey, Nathan Hamilton, Tamara B Harris, Eleanor M Simonsick, Elsa S Strotmeyer, Ronald I Shorr, Andrea Metti, Ann V Schwartz. JAMA Intern Med 2013
191
33

Evaluation of a new measure of blood glucose variability in diabetes.
Boris P Kovatchev, Erik Otto, Daniel Cox, Linda Gonder-Frederick, William Clarke. Diabetes Care 2006
212
33

Associations between HbA1c and continuous glucose monitoring-derived glycaemic variables.
I B Hirsch, J B Welsh, P Calhoun, S Puhr, T C Walker, D A Price. Diabet Med 2019
16
33


Relationships between time in range, glycemic variability including hypoglycemia and types of diabetes therapy in Japanese patients with type 2 diabetes mellitus: Hyogo Diabetes Hypoglycemia Cognition Complications study.
Norihiro Kuroda, Yoshiki Kusunoki, Keiko Osugi, Mana Ohigashi, Daisuke Azuma, Hiroki Ikeda, Shinya Makino, Akihito Otsuka, Daisuke Tamada, Nobuaki Watanabe,[...]. J Diabetes Investig 2021
4
33


Frequency of hypoglycemia and its significance in chronic kidney disease.
Maureen F Moen, Min Zhan, Van Doren Hsu, Lori D Walker, Lisa M Einhorn, Stephen L Seliger, Jeffrey C Fink. Clin J Am Soc Nephrol 2009
222
33

Accuracy of FreeStyle Libre in Adults with Type 1 Diabetes: The Effect of Sensor Age.
Michael Tsoukas, Joanna Rutkowski, Anas El-Fathi, Jean-François Yale, Sarah Bernier-Twardy, Anne Bossy, Evelyne Pytka, Laurent Legault, Ahmad Haidar. Diabetes Technol Ther 2020
3
33

Continuous glucose monitoring reveals hypoglycemia risk in elderly patients with type 2 diabetes mellitus.
Takahiro Ishikawa, Masaya Koshizaka, Yoshiro Maezawa, Minoru Takemoto, Yoshiharu Tokuyama, Toshihiro Saito, Koutaro Yokote. J Diabetes Investig 2018
15
33

Risk Factors of Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Study Based on Continuous Glucose Monitoring.
Keiichi Torimoto, Yosuke Okada, Maiko Hajime, Kenichi Tanaka, Yoshiya Tanaka. Diabetes Technol Ther 2018
12
33

Severe hypoglycemia and risks of vascular events and death.
Sophia Zoungas, Anushka Patel, John Chalmers, Bastiaan E de Galan, Qiang Li, Laurent Billot, Mark Woodward, Toshiharu Ninomiya, Bruce Neal, Stephen MacMahon,[...]. N Engl J Med 2010
900
33

Different Indexes of Glycemic Variability as Identifiers of Patients with Risk of Hypoglycemia in Type 2 Diabetes Mellitus.
Ana M Gómez, Oscar M Muñoz, Alejandro Marin, Maria Camila Fonseca, Martin Rondon, María Alejandra Robledo Gómez, Andrei Sanko, Dilcia Lujan, Maira García-Jaramillo, Fabian Mauricio León Vargas. J Diabetes Sci Technol 2018
14
33

Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes.
Jan P Bremer, Kamila Jauch-Chara, Manfred Hallschmid, Sebastian Schmid, Bernd Schultes. Diabetes Care 2009
164
33

Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes.
Louis Monnier, Claude Colette, Anne Wojtusciszyn, Sylvie Dejager, Eric Renard, Nicolas Molinari, David R Owens. Diabetes Care 2017
120
33

Correlation between minimal secretory capacity of pancreatic beta-cells and stability of diabetic control.
M Fukuda, A Tanaka, Y Tahara, H Ikegami, Y Yamamoto, Y Kumahara, K Shima. Diabetes 1988
121
33

Effect of short-term treatment with sitagliptin or glibenclamide on daily glucose fluctuation in drug-naïve Japanese patients with type 2 diabetes mellitus.
Ryo Suzuki, Jun-Ichi Eiki, Takashi Moritoyo, Kenichi Furihata, Akira Wakana, Yukari Ohta, Shigeru Tokita, Takashi Kadowaki. Diabetes Obes Metab 2018
3
33

Drug-induced hypoglycemic coma in 102 diabetic patients.
H Ben-Ami, P Nagachandran, A Mendelson, Y Edoute. Arch Intern Med 1999
124
33

Glycemic variability correlates strongly with postprandial beta-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents.
Klaus-Dieter Kohnert, Petra Augstein, Eckhard Zander, Peter Heinke, Karolina Peterson, Ernst-Joachim Freyse, Roman Hovorka, Eckhard Salzsieder. Diabetes Care 2009
69
33

Glycemic Variability on Continuous Glucose Monitoring System Correlates With Non-Culprit Vessel Coronary Plaque Vulnerability in Patients With First-Episode Acute Coronary Syndrome - Optical Coherence Tomography Study.
Masaomi Gohbara, Kiyoshi Hibi, Takayuki Mitsuhashi, Nobuhiko Maejima, Noriaki Iwahashi, Shunsuke Kataoka, Eiichi Akiyama, Kengo Tsukahara, Masami Kosuge, Toshiaki Ebina,[...]. Circ J 2016
31
33


Are Risk Indices Derived From CGM Interchangeable With SMBG-Based Indices?
Chiara Fabris, Stephen D Patek, Marc D Breton. J Diabetes Sci Technol 2015
22
33

Relationship between glucose variability evaluated by continuous glucose monitoring and clinical factors, including glucagon-stimulated insulin secretion in patients with type 2 diabetes.
Makoto Ohara, Munenori Hiromura, Hiroe Nagaike, Yo Kohata, Tomoki Fujikawa, Satoshi Goto, Nobuko Sato, Hideki Kushima, Michishige Terasaki, Takeshi Yamamoto,[...]. Diabetes Res Clin Pract 2019
5
33


The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes.
Ji Eun Jun, Sang-Man Jin, Jongha Baek, Sewon Oh, Kyu Yeon Hur, Myung-Shik Lee, Moon-Kyu Lee, Jae Hyeon Kim. Cardiovasc Diabetol 2015
54
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.